Shirish Dabir
Keine laufenden Positionen mehr
Karriereverlauf von Shirish Dabir
Ehemalige bekannte Positionen von Shirish Dabir
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ELANTAS BECK INDIA LIMITED | Compliance Officer | 03.04.2006 | 31.08.2018 |
| Personalreferent | 03.04.2006 | 31.08.2018 | |
| Investor Relations Kontakt | 03.04.2006 | 31.08.2018 | |
| General Counsel | 03.04.2006 | 31.08.2018 | |
| Unternehmenssekretär | 03.04.2006 | 31.08.2018 | |
Emcure Pharmaceuticals Ltd.
 Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Unternehmenssekretär | - | - |
Statistik
International
| Indien | 3 |
Operativ
| Corporate Secretary | 2 |
| Compliance Officer | 1 |
| Human Resources Officer | 1 |
Sektoral
| Process Industries | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ELANTAS BECK INDIA LIMITED | Process Industries |
| Private Unternehmen | 1 |
|---|---|
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Health Technology |
- Börse
- Insiders
- Shirish Dabir
- Erfahrung